Albumin Market Insights, Size, Share, Growth and Forecast to 2030

agregó una foto Health

2023-09-29 08:14:26 - Translate -

Rising adoption of recombinant albumin-based drug delivery systems by pharmaceutical and biotechnology companies is one of the key factors driving the albumin (as excipient) market. For instance, in 2014, Novozymes Biopharma DK A/S announced that its albumin-based VELTIS technology is used by GlaxoSmithKline plc in the manufacturing of type II diabetes drug (Tanzeum and Eperzan) in Europe....

0 Commentarios 0 Acciones 1K Views 0 Vista previa